Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
2.290
0.00 (0.00%)
Feb 27, 2026, 4:00 PM EST - Market closed
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $88.38 million as of February 27, 2026. Its market cap has decreased by -41.13% in one year.
Market Cap
88.38M
Enterprise Value
-11.56M
1-Year Change
-41.13%
Ranking
Category
Stock Price
$2.29
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $88.38M, a decrease of -81.89%. That is a compound annual growth rate of -30.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 88.38M | -22.37% |
| Dec 31, 2025 | 113.85M | -58.58% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyperfine | 109.80M |
| Neuronetics | 97.25M |
| Picard Medical | 84.76M |
| MaxCyte | 84.55M |
| Baird Medical Investment Holdings | 83.74M |
| Xtant Medical Holdings | 80.95M |
| InspireMD | 77.54M |
| Accuray | 69.48M |